Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 2.26%. However, over the past six months, we’ve seen a weaker performance of 0.37%. The price of XBIO fallen by 33.95% over the last 30 days. And in the last five days, it has surged by 48.91%.
In terms of market performance, Xenetic Biosciences Inc had a fairly even. The highest value for the stock in the past year was $5.20 on 06/25/25, and the lowest value was recorded at $2.20 on 04/07/25.
52-week price history of XBIO Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Xenetic Biosciences Inc’s current trading price is -21.54% away from its 52-week high, while its distance from the 52-week low is 85.45%. The stock’s price range during this period has varied between$2.20 and $5.20. The Xenetic Biosciences Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.86 million for the day, a figure considerably higher than their average daily volume of 17080.0 over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Xenetic Biosciences Inc (XBIO) has experienced a quarterly rise of 21.07% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.29M and boasts a workforce of 2 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
XBIO’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for XBIO stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
